Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation

Mohamad Mohty(Sorbonne Université), Florent Malard(Sorbonne Université), Michaël Abécassis(IPO Porto), Erik Aerts(University Hospital of Zurich), Ahmed Alaskar(King Saud bin Abdulaziz University for Health Sciences), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Mutlu Arat(Istanbul Florence Nightingale Hospital), Peter Bader(Goethe University Frankfurt), Frédéric Baron(University of Liège), Ali Bazarbachi(American University of Beirut), Didier Blaise(Institut Paoli-Calmettes), Fabio Ciceri(Vita-Salute San Raffaele University), Selim Corbacioglu(University of Regensburg), J-H Dalle(Délégation Paris 7), Fiona L. Dignan(Manchester University NHS Foundation Trust), Takahiro Fukuda, Anne Huynh(Institut universitaire du cancer de Toulouse Oncopole), Tamás Masszi(Semmelweis University), Mauricette Michallet(Université Claude Bernard Lyon 1), Arnon Nagler(Sheba Medical Center), Mairéad NíChonghaile(Trinity College Dublin), S. Okamoto(Keio University), Antonio Pagliuca(King's College Hospital), Christina Peters(St Anna Children's Hospital), Finn Bo Petersen(LDS Hospital), Paul G. Richardson(Dana-Farber Cancer Institute), Tapani Ruutu(Helsinki University Hospital), Bipin N. Savani(Vanderbilt University Medical Center), Elisabeth Wallhult(Sahlgrenska University Hospital), Ibrahim Yakoub‐Agha(Inserm), Rafael F. Duarte(Hospital Universitario Puerta de Hierro Majadahonda), Enric Carreras(Josep Carreras Leukaemia Research Institute)
Bone Marrow Transplantation
May 16, 2016
Cited by 526Open Access
Full Text

Abstract

Sinusoidal obstruction syndrome, also known as veno-occlusive disease (SOS/VOD), is a potentially life threatening complication that can develop after hematopoietic cell transplantation. Although SOS/VOD progressively resolves within a few weeks in most patients, the most severe forms result in multi-organ dysfunction and are associated with a high mortality rate (>80%). Therefore, careful attention must be paid to allow an early detection of SOS/VOD, particularly as drugs have now proven to be effective and licensed for its treatment. Unfortunately, current criteria lack sensitivity and specificity, making early identification and severity assessment of SOS/VOD difficult. The aim of this work is to propose a new definition for diagnosis, and a severity-grading system for SOS/VOD in adult patients, on behalf of the European Society for Blood and Marrow Transplantation.


Related Papers